Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ROCK2 | O75116 | 1/20 | 0.53 |
| ▸ | ELANE | P08246 | 10/20 | 0.49 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 5/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | IKBKB | O14920 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9826855 | 0.83 | CA12 (0.49) | MRGPRX4CYP3A4IKBKB | |
| SCHEMBL30339521 | 0.80 | ELANE (0.58) | ELANECA2 | |
| SCHEMBL12618375 | 0.80 | ELANE (0.58) | ELANECA2 | |
| SCHEMBL6586179 | 0.78 | MRGPRX4 (0.47) | MRGPRX4CYP3A4IKBKB | |
| SCHEMBL9828031 | 0.78 | CYP3A4 (0.50) | ROCK2CYP3A4 | |
| SCHEMBL29181827 | 0.77 | ROCK2 (0.42) | ROCK2ELANECA2CYP3A4 | |
| SCHEMBL30048870 | 0.77 | ROCK2 (0.42) | ROCK2ELANECA2CYP3A4 | |
| SCHEMBL19400658 | 0.77 | ELANE (0.59) | ELANECA2 | |
| SCHEMBL10457815 | 0.76 | ELANE (0.53) | ELANECA2 | |
| SCHEMBL10457691 | 0.76 | ELANE (0.56) | ELANECA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230041563-A1 | N-(1,3,4-OXADIAZOL-2-YL)ARYLCARBOXAMIDES OR SALTS THEREOF, PREPARATION METHODS, HERBICIDAL COMPOSITIONS AND USES THEREOF | QINGDAO KINGAGROOT CHEMICAL COMPOUND CO., LTD. (CN) | 2023-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230041563-A1 | N-(1,3,4-OXADIAZOL-2-YL)ARYLCARBOXAMIDES OR SALTS THEREOF, PREPARATION METHODS, HERBICIDAL COMPOSITIONS AND USES THEREOF | CYP2B6, CBR3, CYP2A6 | ROCK2 2537/4885ELANE 4842/4885MRGPRX4 2687/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.